Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00829556 · ClinicalTrials.gov registry record · NA
Efficacy of InteguSeal for Surgical Skin Preparation in Patients Undergoing Total Joint Replacement
A NA study, sponsored by Rothman Institute Orthopaedics.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT00829556 is a NA study that has completed, run by Rothman Institute Orthopaedics. The registered enrollment target is 160 participants.
The verdict
NCT00829556, a NA study, has completed, sponsored by Rothman Institute Orthopaedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
This study is being conducted to investigate the potential benefits of using a special type of fluid that can be applied to the skin (Integuseal) in addition to standard surgical skin preparation in patients undergoing total hip replacement (THA) or total knee replacement (TKA). Integuseal is supposed to lock down the skin bacteria and reduce skin infection and other problems. This study will investigate whether Integuseal is effective in reducing persistent wound drainage when used in addition to standard surgical skin preparation for total hip arthroplasty (THA) or total knee replacement (TKA).
Interventions
- DEVICE Integuseal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00829556
The ClinicalTrials.gov registry entry for NCT00829556 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rothman Institute Orthopaedics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Integuseal is the first listed.
NCT00829556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00829556 about?
NCT00829556 is a clinical study titled "Efficacy of InteguSeal for Surgical Skin Preparation in Patients Undergoing Total Joint Replacement". This study is being conducted to investigate the potential benefits of using a special type of fluid that can be applied to the skin (Integuseal) in addition to standard surgical skin preparation in patients undergoing total hip replacement (THA) or total knee replacement (TKA). Integuseal is suppos...
What is the current status of trial NCT00829556?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2008-04. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00829556?
The interventions under investigation include: Integuseal (DEVICE).
Who is sponsoring clinical trial NCT00829556?
This trial is sponsored by Rothman Institute Orthopaedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.